CLINICAL_TRIALS
trial_result
· 2022-07-28
Clinical Trial Update: The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis [Phase 2]
Summary
Phase 2 trial evaluating the effect of riboflavin on moderate to severe plaque psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-07-28